Immunoreactive serum leptin was analysed in 49 women with polycystic ovary syndrome (PCOS) distributed on a wide range of body mass index (BMI; kg/m 2 ) and in 32 normally menstruating women with comparable age, BMI, physical activity and dietary habits. All women with PCOS had increased androgen concentrations and obese women with PCOS (BMI ജ25, n ⍧ 24) also showed decreased insulin sensitivity and a preferential accumulation of truncal-abdominal body fat. Anthropometric and hormonal variables, insulin sensitivity, and pancreatic betacell activity were investigated in all women. Percentage body fat was calculated using gender-specific regression equations based on skinfold measurements. Serum leptin concentrations were higher in obese than in non-obese women (P < 0.001), but did not differ between the women with PCOS and controls, nor did they differ between glucose intolerant and glucose tolerant, or hirsute and nonhirsute women with PCOS. Both groups showed strong correlations between serum leptin concentrations and percentage body fat, BMI, body fat distribution, fasting plasma insulin and C-peptide, early insulin secretion, the free androgen index (FAI), and the degree of insulin resistance. After correcting for percentage body fat, only the FAI in the women with PCOS remained significant (P < 0.05). However, in a multiple regression analysis with both percentage body fat and the FAI as independent variables, the FAI increased only minimally (2%) the explained variation in leptin concentrations. Thus, serum leptin concentrations are almost exclusively determined by the total amount of body fat, independent of its location, and do not confirm the hypothesis that leptin is involved in the development of the hormonal and metabolic abnormalities in the PCOS.
Introduction
Leptin is a recently identified protein hormone encoded by the ob gene, which is expressed in the adipocytes (Zhang et al., 1994) . In rodents, leptin contributes to the regulation of energy balance and reduces percentage body fat . In humans, leptin resistance could be involved in the development of obesity (Caro et al., 1996) . Both in animals and humans Considine et al., 1996) serum leptin concentrations correlate positively with total body mass and percentage body fat. However, the large variation in leptin concentrations among individuals with similar body composition suggests that other factors modulate leptin secretion. There are indications that fat from different locations may produce different amounts of leptin (Masuzaki et al., 1995) , and that hyperinsulinaemia (Leroy et al., 1996) and insulin resistance (Segal et al., 1996) could be associated with increased leptin concentrations. Thus, leptin could be involved in the pathogenesis of the insulin resistance syndrome (de Courten et al., 1997) . Gender differences in leptin concentrations (Ostlund et al., 1996) also suggest that sex steroids could be involved in the control of leptin production, and increased concentrations of glucocorticoids are associated with increased leptin concentrations (Leal-Cerro et al., 1996; Ur et al., 1996) .
Women with the polycystic ovary syndrome (PCOS) represent an ideal clinical model for studying these relationships, since they show a high incidence of various features of the insulin resistance syndrome (Holte, 1996) , such as truncalabdominal obesity (Bringer et al., 1993; Holte, 1996) , insulin resistance (Dunaif et al., 1989; Dale et al., 1992; Robinson et al., 1992; Holte et al., 1994a) , dyslipidaemia (Conway et al., 1992; Holte et al., 1994b) and hypertension (Conway et al., 1992 , in association with hyperandrogenism and an increased activity of the adreno-cortical axis (Azziz et al., 1991 (Azziz et al., , 1995 Lanzone et al., 1995) . Concentrations of serum leptin were recently found to be disproportionately high in relation to body mass index (BMI; kg/m 2 ) in a subgroup of women with PCOS (Brzechffa et al., 1996) , suggesting that a partial leptin resistance could be a feature of PCOS. In the same study, signs of insulin resistance were associated with leptin concentrations 2-fold higher in women with PCOS than in controls. Conversely, another recent study showed similar serum leptin concentrations in women with PCOS and normal women, and there was no independent effect of hyperinsulinaemia on serum concentrations of leptin (Chapman et al., 1997) .
In order to further clarify the role of leptin in PCOS, we analysed serum immunoreactive leptin in a group of women with PCOS and a group of normal women, both groups being part of a previous large cross-sectional study (Holte et al., 1994a) . Indices of body fat distribution, caloric intake, and physical activity were investigated in all women. Insulin sensitivity, pancreatic beta-cell activity and glucose tolerance were separately evaluated using the euglycaemic-hyperinsulinaemic clamp and an intravenous glucose tolerance test (IVGTT). The aims were to investigate whether leptin concentrations differed between women with PCOS and normal women, and whether leptin concentrations correlated with the amount of abdominal fat, insulin resistance or androgenicity in these women.
Materials and methods
Immunoreactive leptin was measured in frozen samples of serum (-70°C) from 49 women with PCOS and 32 normal women, both groups being part of a previous cross-sectional study (Holte et al., 1994a) . The diagnosis of PCOS was based on ultrasonographic evidence of polycystic ovaries (Adams et al., 1986) and the presence of chronic anovulation. The controls had regular menstrual cycles and normal ovaries according to ultrasonography. Twenty-five (51%) women with PCOS and none of the controls were hirsute, according to a modified version of the Ferriman and Gallwey protocol (Hatch et al., 1981) (cut-off for hirsutism was a score Ͼ7). All the women were in good physical condition, non-diabetic, normotensive, with normal concentrations of prolactin, and did not suffer from any other metabolic disease. The degree of physical activity, assessed by a questionnaire, was comparable between the groups (data not shown). None of the women was on a diet programme or had been taking any drug known to affect carbohydrate metabolism, or any hormonal substance for at least 3 months prior to the metabolic and endocrine investigations. The main clinical, anthropometric, hormonal, and metabolic characteristics of the two groups of women are shown in Tables I and II. The groups had similar age and BMI. The ratio between the waist and the hip circumferences (waist:hip ratio) did not differ, whereas the women with PCOS had a preferential accumulation of subcutaneous fat in the upper part of the body according to the sum of the truncal-abdominal (i.e. umbilical, subscapular and suprailiac) skinfolds, the sum of the thigh (anterior and posterior) skinfolds and the ratio between the two sums (skinfold ratio). The methods for these anthropometric measurements were previously described in detail (Holte et al., 1994a) . Percentage body fat was calculated by gender-specific regression equations validated by comparison to underwater weighing (Pollock et al., 1975) , using age, the hip circumference, and the triceps (measured half-way between the acromion process and olecranon process), the thigh anterior and the suprailiac skinfolds. The two groups had comparable body adiposity (Table I ). The women with PCOS had higher ovarian 536 volume, luteinizing hormone (LH)/follicle stimulating hormone (FSH) ratio, free androgen index (FAI), concentrations of LH, testosterone and androstendione, and lower concentrations of FSH and sex hormone binding globulin (SHBG) than the control women. Serum concentrations of oestradiol, progesterone, dihydroepiandrosterone sulphate (DHEA-S) and cortisol did not differ between the groups. Fasting plasma concentrations of insulin and C-peptide were higher in the PCOS women, whereas fasting plasma glucose concentration was similar in the two groups. The insulin sensitivity index (M/I), i.e. the ratio between the glucose infused during the last 60 min of the euglycaemic-hyperinsulinaemic clamp and the steady state plasma insulin concentrations during the same time (Holte et al., 1994a) , was lower in the women with PCOS. The insulin area under the curve (insulin AUC) during the IVGTT (Holte et al., 1994a) was higher in the women with PCOS [PCOS: (mean Ϯ SD) 2447 Ϯ 2184 versus controls: 1503 Ϯ 900; P Ͻ 0.05], whereas the glucose AUC was comparable between the groups (data not shown). The disappearance rate of plasma glucose (calculated as k-value) was lower in the women with PCOS (P Ͻ 0.05), with seven women displaying glucose intolerance (k-value Ͻ1). The early insulin increment in response to i.v. glucose was higher in the women with PCOS than in controls after adjusting for glucose tolerance (PCOS: 68.5 Ϯ 41.9 versus controls: 40.4 Ϯ 31.8; P Ͻ 0.01). A detailed description of the methods for the hormonal and metabolic investigations was previously reported (Holte et al., 1994a,b) . Serum leptin was measured by radioimmunoassay (Human Leptin RIA kit, Linco Research, St Charles, MO, USA). Samples were assayed in duplicate in one of two assays. The intra-assay coefficients of variation were Ͻ5% at 2-20 µg/l and 10% at 0.6 and 70 µg/l. The detection limit was 0.2 µg/l.
Statistics
All variables were examined for normality of distribution with Kolmogorov-Smirnov goodness-of-fit test and, where necessary, log transformation was performed. Comparisons between the groups were performed by non-paired Student's t-test (two-tail), and analysis of variance (ANOVA) followed by appropriate ad-hoc tests when comparisons were made between more than two groups. In the case of persistent skewness of the distribution after log transformation, Wilcoxon's rank sum test was used. Pearson's product-moment correlation was used to estimate linear relationships between variables. Analysis of covariance (ANCOVA) was used to investigate whether the correlations between anthropometric, hormonal, metabolic vari- ables and serum leptin differed between the two groups of women, also after adjusting for percentage body fat. Data are expressed as mean Ϯ SD.
Results
Serum leptin concentrations were similar in the women with PCOS and the controls (Figure 1) . When subdividing the groups in obese (BMI ജ25) and non-obese (BMI Ͻ25) women, both obese women with PCOS and obese controls had higher leptin concentrations than the non-obese subgroups, but both obese and non-obese PCOS women showed leptin concentra- tions similar to their respective controls (Figure 2 ). Similar serum leptin concentrations were also obtained when comparing the seven glucose intolerant women with PCOS versus either the glucose tolerant women with PCOS or the controls (data not shown), or when comparing hirsute versus either non-hirsute women with PCOS or controls (data not shown). Table III gives univariate correlations between serum leptin and the variables which showed the strongest correlations, in both groups. Percentage body fat showed the greatest degree of linear correlation, accounting for 67 and 73% of leptin variation in the control women and in the women with PCOS, respectively ( Figure 3) . BMI, the sum of upper body skinfolds and the sum of thigh skinfolds, and the waist and hip girths also showed strong correlations with leptin, whereas the skinfold ratio and the waist:hip ratio correlated less strongly. After adjusting for percentage body fat, none of these correlations was statistically significant in either group. The FAI was correlated positively with serum leptin concentrations in the women with PCOS, also after adjusting for percentage body fat (P Ͻ 0.05). Positive correlations between leptin and fasting insulin (Figure 4 ), C-peptide, the early insulin increment during IVGTT, and a negative correlation with the M/I value ( Figure 5 ) were found in both groups. After adjusting for percentage body fat, only the correlation with M/I remained close to significant in the PCOS group (P ϭ 0.05). However, adding either FAI or M/I to percentage body fat in the regression model for the women with PCOS increased the explained variation in serum leptin from 73 to 75% in both cases. Leptin concentrations showed no significant correlation with age. No correlations were observed between serum leptin and any of the other hormones investigated, in either group.
Discussion
In this study we tested the hypothesis that abnormal leptin concentrations could be associated with obesity and with the metabolic and hormonal aberrations in women with PCOS. Our results failed to show any differences in serum leptin between the women with PCOS and their controls, despite different hormonal patterns, body fat distribution, insulin sensitivity, and beta-cell function. Moreover, among the women with PCOS serum leptin concentrations were not affected by the presence of glucose intolerance or hirsutism. Our results confirm those of a recent investigation (Chapman et al., 1997) , whereas they are at variance with another study (Brzechffa et al., 1996) , which reported higher serum leptin concentrations in women with PCOS than in normal women. However, the differences in leptin concentrations in the latter study were accounted for by a subset of the women with PCOS (29%) who showed serum leptin concentrations disproportionately high in relation to BMI, whereas the majority of the women with PCOS showed a substantial overlap of individual values with the control women. It is possible that some women with PCOS have increased leptin concentrations compared to normally cycling women, but our and others' (Chapman et al., 1997) results suggest that this does not represent a predominant feature of PCOS. Our findings also showed that the most important predictor of the variation in serum leptin in both groups was percentage body fat, in line with previous reports from other human populations Considine et al., 1996; Ryan and Elahi, 1996) . In the present study, body fat was measured indirectly, by using equations with anthropometric measurements, a method that could have obvious limitations when compared to direct techniques. However, body fat estimates resulting from these equations show a high degree of correlation with the results of a more accurate technique, such as underwater weighing (Pollock et al., 1975 (Pollock et al., , 1980 . Interestingly, our results are strikingly similar to those of a recent study on normal subjects of both sexes, where the same equations were used to calculate percentage body fat (Ostlund et al., 1996) .
Serum leptin was correlated with measures of body fat distribution, similarly in women with PCOS and controls. Waist:hip ratio, an approximate measure of visceral adiposity 539 (Evans et al., 1984) , did not differ between the groups. However, compared with controls the women with PCOS showed a clear predominance of truncal-abdominal subcutaneous fat, which differs morphologically and metabolically from lower-body fat (Kissebah et al., 1982; Martin and Jensen, 1991) . Adjusting for total body adiposity resulted in loss of correlation of serum leptin with waist:hip ratio as well with skinfolds in both groups, confirming previous findings in both healthy individuals Ryan and Elahi, 1996) and women with PCOS (Brzechffa et al., 1996; Chapman et al., 1997) . Thus, these findings support the interpretation that the type of fat does not affect serum leptin concentrations, at least in humans.
Only overweight women with PCOS in our study showed decreased insulin sensitivity. Immunoreactive leptin concentrations were negatively correlated to insulin sensitivity equally in both groups of women. A recent study on lean and obese men reported an association between insulin resistance and plasma leptin, independent from plasma insulin concentrations (Segal et al., 1996) . However, in the present study the impact of insulin resistance on serum leptin, if any, was of small magnitude. Although after adjusting for body fat the correlation was still close to significant in the women with PCOS, little of the variation in leptin concentrations could be explained by the insulin sensitivity index when percentage body fat was included in the prediction model. These results are in agreement with those of recent reports in Pima Indians with varying insulin sensitivity (Pratley et al., 1996) and in postmenopausal Scandinavian women (Larsson and Ahren, 1996) . A previous study on leptin in women with PCOS (Brzechffa et al., 1996) , where insulin sensitivity was measured with the minimal model technique, reported no correlation between the insulin sensitivity index and serum leptin in women with PCOS. In the same study, insulin resistant women with PCOS had 2-fold higher serum leptin concentrations than insulin resistant controls of similar BMI. In our study, 23 women with PCOS (22 obese and one non-obese) but only three controls (two obese and one non-obese) were insulin resistant [cut off: M/I value of 5.1 (Berglund and Lithell, 1996) ], making it impossible to evaluate the independent effect of insulin resistance on leptin concentrations. However, none of the insulin resistant controls had leptin values below the 30th percentile of the leptin distribution for the insulin resistant women with PCOS.
The administration of insulin to rodents acutely increases leptin mRNA concentrations in fat cells, regardless of its glucose-lowering effects (Saladin et al., 1995) , suggesting a direct mechanism of action. This rapid modulatory activity of insulin has not been confirmed in humans (Dagogo-Jack et al., 1996) . However, long-term exposure to hyperinsulinaemia may raise leptin concentrations in normal individuals (Kolaczynski et al., 1996) . In the present study, we found no independent association between fasting insulin concentrations and serum leptin in either group of women. This is in accord with the findings in a recent report on normal weight and overweight women (Havel et al., 1996) , but at variance with the results of other studies where the positive correlations between either fasting serum insulin (Ryan and Elahi, 1996) or the 24 h serum insulin profile (Laughlin and Yen, 1996) and leptin were independent of adiposity in normal women and female athletes, respectively. These contradictory findings might reflect more complex relationships between insulin and leptin in humans than in rodents. The prolonged time of exposure to hyperinsulinaemia needed both in vivo and in vitro (subcutaneous fat cells) to affect leptin production (Kolaczynski et al., 1996) , suggests an indirect activity of insulin, probably via its trophic action on adipocytes . This could be a reason for the stronger correlation of leptin to percentage body fat than to insulin observed in our study. Another suggested mechanism would be a modulatory effect of leptin on betacell function either directly or centrally mediated (Ryan and Elahi, 1996) . However, our results do not confirm this hypothesis, since the correlation between the early insulin increment in response to i.v. glucose, an index of beta-cell activity, and serum leptin, was lost in both groups after accounting for body fat.
In animal models, leptin has a direct stimulatory effect on gonadotrophin production, ovarian follicle development, ovulation and ovarian size (Barash et al., 1996; Chehab et al., 1996) . Expression of both leptin (Cioffi et al., 1997) and its specific receptors (Cioffi et al., 1996) has been recently found in the human ovary. Together, these findings suggested that leptin may play a role in the reproductive functions in humans, and be of particular importance in the contest of reduced fertility in obesity and PCOS (Conway and Jacobs, 1997) . In our study, the women with PCOS had comparable leptin serum concentrations, despite strongly dissimilar hormonal patterns and larger ovaries compared with the control women. Although a weak association between the FAI and leptin was found in the women with PCOS, these results do not support a role for leptin as a direct modulator of reproductive function in PCOS.
In conclusion, despite differences in body fat distribution, androgen concentrations, fasting insulin, insulin sensitivity, glucose tolerance, and pancreatic beta-cell function between women with PCOS and normally cycling women with normal ovaries, the groups had similar serum concentrations of immunoreactive leptin. The percentage of body fat was the single most important variable associated with serum leptin in both groups. The present results strongly argue against a role for leptin in the development of the hormonal and metabolic abnormalities in women with PCOS.
